MedShape to demonstrate ExoShape interference fixation device for ACL reconstruction

NewsGuard 100/100 Score

What  

  • MedShape will be demonstrating the recently introduced ExoShape™ interference fixation device for ACL reconstruction that preserves soft tissue graft orientation, provides superior graft protection, and class-leading fixation.
  • ExoShape™ CL, a two-part PEEK Altera™ interference fixation device simplifies and improves soft tissue graft fixation during anterior cruciate ligament (ACL) reconstructive surgery. The product was recently used successfully for the first time in a knee ligament reconstruction procedure performed by Champ L. Baker, Jr., M.D., at the Jack Hughston Memorial Hospital in Phenix City, Alabama.
  • ExoShape's design supports the evolution of reconstruction techniques to more accurately replicate complex native ACL functionality. This unique fixation device features a non-rotational deployment technique that preserves the surgeon's desired soft tissue graft bundle orientation and tension during single-tunnel double-bundle procedures, eliminating undesirable variables common to previous techniques.
  • Demonstration of the device in the booth and animation of the procedure featured.
  • Medical representatives on site to provide answers to surgical technique questions.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.